ERLIN2 Gene SPG18 Genetic Test
Test Name: ERLIN2 Gene SPG18 Genetic Test
Components: DNA Labs UAE
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for ERLIN2 Gene SPG18 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ERLIN2 Gene SPG18.
Test Details:
The ERLIN2 gene is associated with a form of hereditary spastic paraplegia known as SPG18. SPG18 is a rare neurodegenerative disorder characterized by progressive stiffness and weakness in the lower limbs.
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously. It allows for the identification of genetic variants or mutations that may be responsible for a particular disease or condition. In the case of SPG18, NGS genetic testing can help determine if there are any mutations in the ERLIN2 gene that may be causing the disorder.
The test involves obtaining a DNA sample, typically through a blood sample or saliva swab, and then sequencing the DNA to identify any genetic changes. The results of the test can help confirm a diagnosis of SPG18 and may also provide information about the specific genetic variant involved.
Genetic testing can be useful for individuals with suspected SPG18, as it can provide a definitive diagnosis, help guide treatment decisions, and offer insight into the risk of passing the condition on to future generations. However, it is important to note that genetic testing is not always necessary or appropriate for everyone and should be discussed with a healthcare professional who specializes in genetics.
| Test Name | ERLIN2 Gene SPG18 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for ERLIN2 Gene SPG18 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ERLIN2 Gene SPG18 |
| Test Details |
The ERLIN2 gene is associated with a form of hereditary spastic paraplegia known as SPG18. SPG18 is a rare neurodegenerative disorder characterized by progressive stiffness and weakness in the lower limbs. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously. It allows for the identification of genetic variants or mutations that may be responsible for a particular disease or condition. In the case of SPG18, NGS genetic testing can help determine if there are any mutations in the ERLIN2 gene that may be causing the disorder. The test involves obtaining a DNA sample, typically through a blood sample or saliva swab, and then sequencing the DNA to identify any genetic changes. The results of the test can help confirm a diagnosis of SPG18 and may also provide information about the specific genetic variant involved. Genetic testing can be useful for individuals with suspected SPG18, as it can provide a definitive diagnosis, help guide treatment decisions, and offer insight into the risk of passing the condition on to future generations. However, it is important to note that genetic testing is not always necessary or appropriate for everyone and should be discussed with a healthcare professional who specializes in genetics. |
